Article
Semaphorin 3A levels in vascular and nonvascular phenotypes in systemic sclerosis.
Laboratory medicine - 2 Nov 2023
Kayaalp Mehmet, Erden Abdulsamet, Apaydin Hakan, Güven Serdar Can, Armağan Berkan, Cağlayan Kayaalp Merve, Andac Uzdogan Esma, Ala Enli Şeymanur, Omma Ahmet, Kucuksahin Orhan
Abstract excerpt
OBJECTIVE: Semaphorin 3A (Sema3A) plays a regulatory role in immune responses. The aim of this study was to evaluate Sema3A levels in patients with systemic sclerosis (SSc), especially in major vascular involvements such as digital ulcer (DU), scleroderma renal crisis (SRC), pulmonary arterial hypertension (PAH), and to compare Sema3A level with SSc disease activity. METHODS: In SSc patients, patients with DU,...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
